 |
|
Long-term clinical course of a patient with mucopolysaccharidosis type IIIB
Ja Hye Kim (Kim JH), Yang Hyun Chi (Chi YH), Gu-Hwan Kim (Kim GH), Han-Wook Yoo (Yoo HW), Jun Hwa Lee (Lee JH)
Clin Exp Pediatr. 2016;59(Suppl 1):S37-S40. Published online 2016 Nov 30 DOI: https://doi.org/10.3345/kjp.2016.59.11.S37
|
|
Citations to this article as recorded by
 Disease progression in Sanfilippo type B: Case series of Brazilian patients
Yorran Hardman Araújo Montenegro, Francyne Kubaski, Franciele Barbosa Trapp, Mariluce Riegel-Giugliani, Carolina Fischinger Moura de Souza, Erlane Marques Ribeiro, Charles Marques Lourenço, Augusto César Cardoso-dos-Santos, Márcia Gonçalves Ribeiro, Chong
Genetics and Molecular Biology.2024;[Epub] CrossRef Clinical, biochemical, and molecular characterization of mucopolysaccharidosis type III in 34 Egyptian patients
Nihal Almenabawy, Manal Ramadan, Mona Kamel, Iman G. Mahmoud, Fawzia Amer, Yara Shaheen, Walaa Elnaggar, Laila Selim
American Journal of Medical Genetics Part A.2023; 191(9): 2354. CrossRef A Novel Mutation (p.Met1?) of a Cuban Patient in the NAGLU Gene with Mucopolysaccharidosis IIIB
Laritza Martínez Rey, Tatiana Acosta Sánchez, Deynis Carmenate Naranjo, Hector Vera Cuesta
Journal of Inborn Errors of Metabolism and Screeni.2021;[Epub] CrossRef Schizophreniform presentation and abrupt neurologic decline in a patient with late-onset mucopolysaccharidosis type IIIB
Yorran Hardman Araújo Montenegro, Guilherme Baldo, Roberto Giugliani, Fabiano de Oliveira Poswar, Ruy Pires de Oliveira Sobrinho, Carlos Eduardo Steiner
Psychiatric Genetics.2021; 31(5): 199. CrossRef
|